Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Sep 30
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Government to nurture AI-specializing medical scientists

Dec 8
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Fund commits to $350M dedicated LS investments

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Oct 1
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Global data and analysis on dealmaking, funding, and exits in private-market companies

Oct 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Big-name U.S. tech investors are moving in on Europe in increasing numbers

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Arabesque launches the world’s first AI-powered ESG portfolio manager

Dec 30
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts predict massive growth in health tech

Oct 7
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Amazon Genomics CLI is Open Source, UK Biobank’s Research Analysis Platform Live

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding